Aquestive Therapeutics, Inc. Common Stock AQST
$3.79
+2.57%
at last close
Financials (TTM)
- Revenue
- $50.27 million
- Net Income
- $-68,911,000
- Net Margin
- -137.08%
- Return on Equity
- 202.36%
- Debt-to-Equity
- -1.32
- P/E Ratio
- —
- Price / Book
- -13.96
- Price / Sales
- 9.46
Over the trailing twelve months, Aquestive Therapeutics, Inc. Common Stock generated revenue of $50.27 million and net income of $-68,911,000, a net margin of -137.08%.
At the last closing price of $3.79, AQST trades at 9.46 times sales, with a market capitalization of $475.52 million.
Key Stats
- Last Close
- $3.79
- Market Cap
- $475.52 million
- 52-Week Range
- $2.93 – $7.55
- Average Volume
- 2.23 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.